Literature DB >> 12586106

A step further in understanding the biology of the folate receptor in ovarian carcinoma.

M Bagnoli1, S Canevari, M Figini, D Mezzanzanica, F Raspagliesi, A Tomassetti, S Miotti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12586106     DOI： 10.1006/gyno.2002.6705

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  14 in total

1.  Role of farletuzumab in epithelial ovarian carcinoma.

Authors:  Danijela Jelovac; Deborah K Armstrong
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  Levels of folate receptor autoantibodies in maternal and cord blood and risk of neural tube defects in a Chinese population.

Authors:  Na Yang; Linlin Wang; Richard H Finnell; Zhiwen Li; Lei Jin; Le Zhang; Robert M Cabrera; Rongwei Ye; Aiguo Ren
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2016-05-11

3.  Simultaneous expression of caveolin-1 and E-cadherin in ovarian carcinoma cells stabilizes adherens junctions through inhibition of src-related kinases.

Authors:  Silvia Miotti; Antonella Tomassetti; Ileana Facetti; Elena Sanna; Valeria Berno; Silvana Canevari
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

Review 4.  Past, present and future targets for immunotherapy in ovarian cancer.

Authors:  Carlton L Schwab; Diana P English; Dana M Roque; Monica Pasternak; Alessandro D Santin
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

5.  Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer.

Authors:  Yunfei Wen; Whitney S Graybill; Rebecca A Previs; Wei Hu; Cristina Ivan; Lingegowda S Mangala; Behrouz Zand; Alpa M Nick; Nicholas B Jennings; Heather J Dalton; Vasudha Sehgal; Prahlad Ram; Ju-Seog Lee; Pablo E Vivas-Mejia; Robert L Coleman; Anil K Sood
Journal:  Clin Cancer Res       Date:  2014-11-21       Impact factor: 12.531

6.  Cancer photothermal therapy in the near-infrared region by using single-walled carbon nanotubes.

Authors:  Feifan Zhou; Da Xing; Zhongmin Ou; Baoyan Wu; Daniel E Resasco; Wei R Chen
Journal:  J Biomed Opt       Date:  2009 Mar-Apr       Impact factor: 3.170

7.  The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer.

Authors:  Lucia M A Crane; Henriette J G Arts; Marleen van Oosten; Philip S Low; Ate G J van der Zee; Gooitzen M van Dam; Joost Bart
Journal:  Cell Oncol (Dordr)       Date:  2011-06-07       Impact factor: 6.730

Review 8.  Lesser-Known Molecules in Ovarian Carcinogenesis.

Authors:  Ludmila Lozneanu; Elena Cojocaru; Simona Eliza Giuşcă; Alexandru Cărăuleanu; Irina-Draga Căruntu
Journal:  Biomed Res Int       Date:  2015-08-03       Impact factor: 3.411

Review 9.  Profile of vintafolide (EC145) and its use in the treatment of platinum-resistant ovarian cancer.

Authors:  Mathieu Luyckx; Raffaella Votino; Jean-Luc Squifflet; Jean-François Baurain
Journal:  Int J Womens Health       Date:  2014-03-31

10.  Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.

Authors:  Spencer D Martin; Scott D Brown; Darin A Wick; Julie S Nielsen; David R Kroeger; Kwame Twumasi-Boateng; Robert A Holt; Brad H Nelson
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.